These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 5060427)

  • 21. Pemphigus controlled by dapsone.
    Piamphongsant T
    Br J Dermatol; 1976 Jun; 94(6):681-6. PubMed ID: 779820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The incidence of agranulocytosis during treatment of dermatitis herpetiformis with dapsone as reported in Sweden, 1972 through 1988.
    Hörnsten P; Keisu M; Wiholm BE
    Arch Dermatol; 1990 Jul; 126(7):919-22. PubMed ID: 2360840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eosinophilic spongiosis in pemphigus. A report of an unusual hitological change in pemphigus.
    Emmerson RW; Wilson-Jones E
    Arch Dermatol; 1968 Mar; 97(3):252-7. PubMed ID: 4295951
    [No Abstract]   [Full Text] [Related]  

  • 24. Dapsone in dermatitis herpetiformis and other immunological diseases.
    Dahl MG
    Lancet; 1977 Feb; 1(8008):429. PubMed ID: 65542
    [No Abstract]   [Full Text] [Related]  

  • 25. Dapsone-induced motor peripheral neuropathy in pemphigus foliaceus.
    Rhodes LE; Coleman MD; Lewis-Jones MS
    Clin Exp Dermatol; 1995 Mar; 20(2):155-6. PubMed ID: 8565254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dapsone and human polymorphonuclear leucocyte chemotaxis in dermatitis herpetiformis.
    Millar BW; Macdonald KJ; Macleod TM; Raffle EJ
    Acta Derm Venereol; 1984; 64(5):433-6. PubMed ID: 6208726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dapsone and severe hypoalbuminaemia in dermatitis herpetiformis.
    Cowan RE; Wright JT
    Br J Dermatol; 1981 Feb; 104(2):201-4. PubMed ID: 7213552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pemphigus herpetiformis - a case report of a rare form of pemphigus and review of the literature.
    Stojković-Filipović J; Lekić B; Milčić D; Milinković MV
    Vojnosanit Pregl; 2016 Oct; 73(10):967-72. PubMed ID: 29328564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical experiments with a combination of methotrexate and corticosteroid treatment in dermatitis herpetiformis and pemphigus vulgaris.
    Randazzo SD; Mirone A
    Ital Gen Rev Dermatol; 1974; 11(2):151-7. PubMed ID: 4470102
    [No Abstract]   [Full Text] [Related]  

  • 30. [Long-term use of DDS by patients with Duhring's herpetiform dermatitis].
    Plechistova LA; Salikhov AS
    Vestn Dermatol Venerol; 1981 Sep; (9):74-6. PubMed ID: 7303890
    [No Abstract]   [Full Text] [Related]  

  • 31. [On the treatment of dermatitis herpetiformis with sulfones].
    Pawlik H
    Przegl Dermatol; 1968; 55(4):535-41. PubMed ID: 5699176
    [No Abstract]   [Full Text] [Related]  

  • 32. [Remote results of the treatment of patients with chronic pemphigus and Duhring's dermatitis herpetiformis].
    Nizar AD
    Vestn Dermatol Venerol; 1970 Mar; 44(3):17-20. PubMed ID: 5469502
    [No Abstract]   [Full Text] [Related]  

  • 33. Long-term combination therapy of ustekinumab and dapsone in a patient with psoriasis and dermatitis herpetiformis Duhring.
    Gkalpakiotis S; Arenberger P; Sticova E; Sefrnova P; Arenbergerova M
    J Dermatol; 2012 Dec; 39(12):1074-5. PubMed ID: 22784106
    [No Abstract]   [Full Text] [Related]  

  • 34. Discontinuing dapsone treatment and reintroducing dietary gluten in patients with dermatitis herpetiformis in remission: comment on "remission in dermatitis herpetiformis".
    Mostow EN
    Arch Dermatol; 2011 Mar; 147(3):305-6. PubMed ID: 21422338
    [No Abstract]   [Full Text] [Related]  

  • 35. [Management of dermatitis herpetiformis].
    Schuppli R
    Dtsch Med Wochenschr; 1968 Nov; 93(48):2343. PubMed ID: 4301398
    [No Abstract]   [Full Text] [Related]  

  • 36. Absorption and excretion of 35S dapsone in dermatitis herpetiformis.
    Alexander JO; Young E; McFadyen T; Fraser NG; Duguid WP; Meredith EM
    Br J Dermatol; 1970 Dec; 83(6):620-31. PubMed ID: 5492474
    [No Abstract]   [Full Text] [Related]  

  • 37. Pemphigus Herpetiformis With Autoantibodies to Desmoglein 1 and 3.
    Galvañ-Pérez Del Pulgar JI; Tercedor-Sánchez J; Jiménez-Gallo D; Linares-Barrios M
    Actas Dermosifiliogr; 2016 Nov; 107(9):785-786. PubMed ID: 27340117
    [No Abstract]   [Full Text] [Related]  

  • 38. Pemphigus herpetiformis in South Tunisia: a clinical expression of pemphigus foliaceus?
    Jerbi A; Hachicha H; Feki S; Bahloul E; Sellami K; Abida O; Charfi S; Bouzid A; Sellami Boudawara T; Turki H; Masmoudi A; Masmoudi H
    Int J Dermatol; 2018 Sep; 57(9):1094-1101. PubMed ID: 30011065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acetylator phenotype, minimal maintenance dose and haemolytic effect of dapsone in dermatitis herpetiformis.
    Förström L; Mattila MJ; Mustakallio KK
    Ann Clin Res; 1974 Oct; 6(5):308-10. PubMed ID: 4447343
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of Duhring's dermatitis herpetiformis in childhood with diaminodiphenylsulfone (DDS)].
    Schwenke W; Ladstätter L; Stolp A
    Padiatr Grenzgeb; 1969; 8(2):109-21. PubMed ID: 5380550
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.